Current role
Dr. Mitchell Shirvan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Mitchell Shirvan
The proxy statement of Silexion Therapeutics Corp reports total compensation of $1,301,490 for Dr. Mitchell Shirvan in fiscal 2024, including a base salary of $190,286. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Silexion Therapeutics Corp (SLXN)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Silexion Therapeutics Corp
Other people whose current roles at this company are on record from its filings.
- Ilan Hadar CEO, Chairman
- Mirit Horenshtein Hadar CFO
- Amnon Peled Board Member
- Avner Lushi Board Member
- Dror Abramov Board Member
- Ilan Levin Board Member
- Ilan Shiloah Board Member
- Ruth Alon Board Member
- Shlomo Noy Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Silexion Therapeutics Corp (SLXN) | Chief Scientific and Development Officer | $190,286 | $1,301,490 |
| 2023 | Silexion Therapeutics Corp (SLXN) | Chief Scientific and Development Officer | $156,140 | $206,800 |
Recent activity
No call appearances or filed executive changes recorded yet.